J E Roulston

1.2k total citations
47 papers, 967 citations indexed

About

J E Roulston is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Reproductive Medicine. According to data from OpenAlex, J E Roulston has authored 47 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Cardiology and Cardiovascular Medicine and 10 papers in Reproductive Medicine. Recurrent topics in J E Roulston's work include Protein Hydrolysis and Bioactive Peptides (11 papers), Ovarian cancer diagnosis and treatment (10 papers) and Renin-Angiotensin System Studies (10 papers). J E Roulston is often cited by papers focused on Protein Hydrolysis and Bioactive Peptides (11 papers), Ovarian cancer diagnosis and treatment (10 papers) and Renin-Angiotensin System Studies (10 papers). J E Roulston collaborates with scholars based in United Kingdom, Sweden and Italy. J E Roulston's co-authors include Nirmala D. Markandu, G. A. MacGregor, Julia C. Jones, Graham A. MacGregor, J. J. Morton, J Bayliss, H. E. de Wardener, S. Fenton, Jamshid Alaghband‐Zadeh and M. Squires and has published in prestigious journals such as Nature, The Lancet and British Journal of Cancer.

In The Last Decade

J E Roulston

45 papers receiving 880 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J E Roulston United Kingdom	18	417	314	214	213	134	47	967
Robert A. Vukovich United States	9	623 1.5×	549 1.7×	276 1.3×	192 0.9×	83 0.6×	19	1.1k
Chiara Troffa Italy	20	705 1.7×	402 1.3×	141 0.7×	724 3.4×	91 0.7×	56	1.5k
Mohammad N Uddin United States	21	255 0.6×	329 1.0×	67 0.3×	210 1.0×	93 0.7×	55	1.1k
Hans-R. Brunner Switzerland	12	748 1.8×	516 1.6×	209 1.0×	252 1.2×	75 0.6×	16	1.2k
Kirsten Müller Germany	6	348 0.8×	277 0.9×	107 0.5×	218 1.0×	79 0.6×	11	1.2k
R. F. Bing United Kingdom	20	565 1.4×	357 1.1×	192 0.9×	443 2.1×	208 1.6×	91	1.6k
Koichi Handa Japan	19	320 0.8×	381 1.2×	53 0.2×	131 0.6×	158 1.2×	48	1.1k
Robert H. Furman United States	18	164 0.4×	260 0.8×	74 0.3×	417 2.0×	139 1.0×	31	1.1k
M Jáchymová Czechia	19	244 0.6×	292 0.9×	110 0.5×	283 1.3×	66 0.5×	67	1.2k
T T Guyenne France	12	455 1.1×	274 0.9×	27 0.1×	346 1.6×	144 1.1×	14	845

Countries citing papers authored by J E Roulston

Since Specialization

Citations

This map shows the geographic impact of J E Roulston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J E Roulston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J E Roulston more than expected).

Fields of papers citing papers by J E Roulston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J E Roulston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J E Roulston. The network helps show where J E Roulston may publish in the future.

Co-authorship network of co-authors of J E Roulston

This figure shows the co-authorship network connecting the top 25 collaborators of J E Roulston. A scholar is included among the top collaborators of J E Roulston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J E Roulston. J E Roulston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roulston, J E & John M.S. Bartlett. (2004). Molecular diagnosis of cancer : methods and protocols. Humana Press eBooks. 5 indexed citations

Roulston, J E. (2002). Screening with Tumor Markers: Critical Issues. Molecular Biotechnology. 20(2). 153–162. 20 indexed citations

Beattie, G. J., et al.. (1993). Alpha-Fucosidase as a Marker of Genetic Deletion in Ovarian Carcinoma. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 30(2). 207–208. 1 indexed citations

Stewart, Moira, et al.. (1993). The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma. British Journal of Cancer. 68(1). 140–145. 20 indexed citations

Roulston, J E, et al.. (1993). The value of the human milk fat globule membrane antigen HMFG2 in epithelial ovarian cancer monitoring: comparison with CA125. British Journal of Cancer. 67(5). 1065–1070. 4 indexed citations

Beattie, G. J., et al.. (1993). The Effect of Surgery on the Serum Concentration of CA125 in Epithelial Ovarian Cancer. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 30(4). 402–403. 1 indexed citations

Ng, Joseph, et al.. (1993). Serological Markers for Metastatic Breast Cancer. Disease Markers. 11(5-6). 217–223. 10 indexed citations

Hayes, Peter, et al.. (1992). GALLSTONES IN DIABETES-MELLITUS - PREVALENCE AND RISK-FACTORS. European Journal of Gastroenterology & Hepatology. 4(1). 55–59. 13 indexed citations

Roulston, J E, et al.. (1992). Investigation of the c-neu proto-oncogene related protein, p185, in the serum of primary epithelial ovarian cancer patients. International Journal of Gynecological Cancer. 2(3). 134–140. 1 indexed citations

10.

Leonard, Robert, et al.. (1992). Serological monitoring of epithelial ovarian cancer.. PubMed. 9(3-4). 175–90. 4 indexed citations

11.

Léonard, Renaud, et al.. (1989). Immunoassay of CA125 in ovarian cancer: a comparison of three assays for use in diagnosis and monitoring.. PubMed. 7(1). 61–7. 5 indexed citations

12.

Léonard, Renaud, et al.. (1989). Serum placental-like alkaline phosphatase (PLAP): a novel combined enzyme linked immunoassay for monitoring ovarian cancer.. Journal of Clinical Pathology. 42(1). 40–45. 20 indexed citations

13.

Bowman, Andrew W., et al.. (1988). Immunoassay of CA125 in Ovarian Cancer: A Comparison of Three Assays. Clinical Science. 74(s18). 39P–40P. 1 indexed citations

14.

Roulston, J E & Donald R. Allan. (1987). Studies with an automated kinetic assay for plasma angiotensin-converting enzyme activity and its potentiation by zinc ion. Clinica Chimica Acta. 168(2). 187–198. 6 indexed citations

15.

Roulston, J E & Peter Galloway. (1986). In vitro inhibition of angiotensin-converting enzyme by prednisolone and methylprednisolone.. Clinical Chemistry. 32(4). 697–698. 1 indexed citations

16.

Wathen, C G, W. J. Hannan, Lindsay W. Turnbull, J E Roulston, & Alexander Muir. (1984). The Use of Nifedipine in Combination Therapy for the Management of Hypertension. Clinical Science. 66(6). 66P.1–66P. 4 indexed citations

17.

MacGregor, G. A., et al.. (1983). Lack of effect of beta-blocker on flat dose response to thiazide in hypertension: efficacy of low dose thiazide combined with beta-blocker.. BMJ. 286(6377). 1535–1538. 46 indexed citations

18.

Roulston, J E, et al.. (1983). The Stability of Angiotensin I Formed at Room Temperature in the Presence of Ethylenediaminetetraacetate to Subsequent Incubation at 37 °C. Clinical Chemistry and Laboratory Medicine (CCLM). 21(11). 703–708. 2 indexed citations

19.

MacGregor, G A, et al.. (1982). Xipamide and cyclopenthiazide in essential hypertension–comparative effects on blood pressure and plasma potassium.. British Journal of Clinical Pharmacology. 13(6). 859–863. 3 indexed citations

20.

MacGregor, G. A., Nirmala D. Markandu, J E Roulston, & Julia C. Jones. (1979). Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.. BMJ. 2(6198). 1106–1109. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact